Locations:
SearchAdvertisement
Perspectives from leading Cleveland Clinic co-investigators
Other factors explain diabetic patients’ poorer outcomes after bypass
Glycemic control, weight loss endure out to five years
No clinical advantage to either rhythm or rate control
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Also finds PCSK9 inhibitor more potent than ezetimibe in statin-intolerant patients
Trial stopped early after evacetrapib fails to budge event rate
Risk factors surge as patients grow younger, more obese
Seven high-profile studies ranging from TAVR to lipid-lowering
Endovascular procedures associated with lower mortality, LOS, cost vs. surgical bypass
Advertisement
Advertisement